Zura Bio Balance Sheet Health
Financial Health criteria checks 6/6
Zura Bio has a total shareholder equity of $172.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $189.5M and $17.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$188.44m |
| Equity | US$172.06m |
| Total liabilities | US$17.44m |
| Total assets | US$189.50m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 94E's short term assets ($189.5M) exceed its short term liabilities ($15.1M).
Long Term Liabilities: 94E's short term assets ($189.5M) exceed its long term liabilities ($2.4M).
Debt to Equity History and Analysis
Debt Level: 94E is debt free.
Reducing Debt: 94E had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 94E has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 94E has sufficient cash runway for 2.8 years if free cash flow continues to reduce at historical rates of 4.2% each year.